Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Baricitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04870203
What this trial is testing

Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University Hospital, Bordeaux 160
Not applicableUnknownNCT06558305
What this trial is testing

IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Assiut University 80
Large-scale testing (Phase 3)Study completedNCT01711359
What this trial is testing

A Study in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 588
Large-scale testing (Phase 3)Study completedNCT02265705
What this trial is testing

Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 290
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07669675
What this trial is testing

TPO-RA Plus Baricitinib vs. TPO-RA for ITP

Who this might be right for
ITP - Immune Thrombocytopenia
Peking University People's Hospital 100
Large-scale testing (Phase 3)Study completedNCT03570749
What this trial is testing

Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Eli Lilly and Company 784
Early research (Phase 1)Study completedNCT05006768
What this trial is testing

Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumiant 4 mg Film Coated Tablets (Eli Lilly Nederland B.V., The Netherlands)

Who this might be right for
Healthy
Genuine Research Center, Egypt 30
Early research (Phase 1)Active Not RecruitingNCT05792462
What this trial is testing

Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum Disorder
Tianjin Medical University General Hospital 11
Early research (Phase 1)Looking for participantsNCT07262983
What this trial is testing

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

Who this might be right for
Hyper IgE Syndrome From STAT3 MutationJob s SyndromeHIES+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT07028385
What this trial is testing

Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HIV-1

Who this might be right for
HIV
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 30
Large-scale testing (Phase 3)UnknownNCT05056558
What this trial is testing

Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19

Who this might be right for
Covid19
Incepta Pharmaceuticals Ltd 480
Large-scale testing (Phase 3)Study completedNCT03952559
What this trial is testing

Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 516
Testing effectiveness (Phase 2)Study completedNCT04901325
What this trial is testing

Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Who this might be right for
Pyoderma GangrenosumSkin DiseasesWound Heal+2 more
Oregon Health and Science University 5
Not applicableStudy completedNCT05082714
What this trial is testing

Tocilizumab Versus Baricitinib in Patients With Severe COVID-19

Who this might be right for
COVID-19
University Hospital of Patras 251
Large-scale testing (Phase 3)Looking for participantsNCT07222137
What this trial is testing

Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 150
Not applicableNot Yet RecruitingNCT07448363
What this trial is testing

Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica

Who this might be right for
Atopic DermatitisAtopic Dermatitis (AD)Atopic Dermatitis (Eczema)+3 more
Caja Costarricense de Seguro Social 50
Testing effectiveness (Phase 2)Study completedNCT00902486
What this trial is testing

INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs

Who this might be right for
Rheumatoid Arthritis
Incyte Corporation 127
Large-scale testing (Phase 3)Study completedNCT01721044
What this trial is testing

A Moderate to Severe Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 527
Large-scale testing (Phase 3)Study completedNCT04358614
What this trial is testing

Baricitinib Therapy in COVID-19

Who this might be right for
COVIDPneumonia
Fabrizio Cantini 12
Testing effectiveness (Phase 2)Ended earlyNCT04373044
What this trial is testing

Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19

Who this might be right for
Symptomatic COVID-19 Infection Laboratory-Confirmed
University of Southern California 6
Next Page